Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/R3X1 stock hub

FRA/R3X1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/R3X1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

302.7M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/R3X1FRA/R3X1

—

Loading chart…

In the news

Latest news · FRA/R3X1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-242.4

P25 n/aP50 n/aP75 n/a

ROIC-114.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/R3X1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

150

Groups with data

Currency

USD

Showing 150 of 150 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	28
Employees Change	4%
Employees Change Percent	28.57
Enterprise value	EUR 265.4M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 302.7M
Price	EUR 4.14
Price currency	EUR
Rev Per Employee	431,811.89x
Sic	2834
Symbol	fra/R3X1
Website	https://opusgtx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.95%
EV Earnings	-6.28x
EV/Sales	22x
P/B ratio	23.16x
P/S ratio	25.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-271.9%
EBITDA Margin	-271.53%
Gross margin	-117.05%
Gross Profit	EUR -14.2M
Net Income	EUR -42.2M
Pretax Margin	-349.33%
Profit Per Employee	EUR -1.5M
ROA	-55.39
Roa5y	-29.93
ROCE	-90.9
ROE	-242.4
Roe5y	-331.7
ROIC	-114.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	386.83%
Cagr3y	-8.44%
Cagr5y	2.97%
Revenue Growth	29.15x
Revenue Growth Q	-10.16x
Revenue Growth3 Y	-29.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.33
Assets	EUR 42.8M
Cash	EUR 38.4M
Current Assets	EUR 42.4M
Current Liabilities	EUR 6.6M
Debt	EUR 961,569
Debt Equity	EUR 0.07
Equity	EUR 13.1M
Interest Coverage	-26.33
Liabilities	EUR 29.7M
Long Term Assets	EUR 356,553
Long Term Liabilities	EUR 23.1M
Net Cash	EUR 37.4M
Net Cash By Market Cap	EUR 12.37
Net Cash Growth	44.98%
Net Debt Equity	EUR -2.86
Tangible Book Value	EUR 13.1M
Tangible Book Value Per Share	EUR 0.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.43
Net Working Capital	EUR -2.4M
Quick ratio	6.2
Working Capital	EUR 36M
Working Capital Turnover	EUR 0.36

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-132.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	386.3%
200-day SMA	2.27
3Y total return	-23.24%
50-day SMA	4.15
50-day SMA vs 200-day SMA	50over200
5Y total return	15.76%
All Time High	15.4
All Time High Change	-72.34%
All Time High Date	2021-03-15
All Time Low	0.58
All Time Low Change	640.87%
All Time Low Date	2025-04-10
ATR	0.23
Ch YTD	157.2
High	4.5
High52	4.84
High52 Date	2026-04-13
High52ch	-14.46%
Low	4.14
Low52	0.72
Low52 Date	2025-07-01
Low52ch	475%
Ma50ch	2.55%
Price vs 200-day SMA	87.34%
RSI	46.03
RSI Monthly	72.43
RSI Weekly	64.74
Sharpe ratio	2.65x
Sortino ratio	4.86
Total Return	-132.91%
Tr YTD	157.2
Tr1m	1.91%
Tr1w	-2.29%
Tr3m	69.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -32.9M
Operating margin	-271.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34,482,938%
Net Borrowing	847,962
Shares Insiders	15.57%
Shares Institutions	32.86%
Shares Qo Q	14.08%
Shares Yo Y	132.91%
Short Ratio	1.96

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	0x
Bv Per Share	0.19
Ch1m	1.91
Ch1w	-2.29
Ch1y	386.3
Ch3m	69.38
Ch3y	-23.24
Ch5y	15.76
Ch6m	148.8
Change	-7.17%
Change From Open	-8
Close	4.46
Days Gap	0.9
Depreciation Amortization	44,942
Earnings Date	2026-05-13
EBIT	EUR -32.9M
EBITDA	EUR -32.8M
EPS	EUR -0.68
F Score	4
Financing CF	42,604,589
Fiscal Year End	December
Founded	2,018
Is Primary Listing	0
Last Report Date	2025-12-31
Ma150	2.67
Ma150ch	59.49%
Ma20	4.46
Ma20ch	-4.55%
Net CF	12,579,609
Next Earnings Date	2026-05-13
Open	4.5
Position In Range	0
Ppne	168,744.4
Price Date	2026-05-08
Ptbv Ratio	23.16
Relative Volume	2,000x
Revenue	12,090,733x
SBC By Revenue	23.94x
Share Based Comp	2,894,928
Tr6m	148.83%
Z Score	-5.2

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/R3X1 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/R3X1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/R3X1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+32.9%

Share of float held by funds and institutions

Insider ownership

+15.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/R3X1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.0

Neutral momentum band

Price vs 200-day MA

+87.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

2.65

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/R3X1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/R3X1 stock rating?

fra/R3X1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/R3X1 analysis?

The full report lives at /stocks/fra/R3X1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/R3X1?

The latest report frames fra/R3X1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/R3X1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.